期刊文献+

经直肠穿刺^125Ⅰ粒子植入联合内分泌治疗局部晚期前列腺癌的临床疗效 被引量:19

Combination of transrectal ^(125)Ⅰ seeds implantation brachytherapy and intermittent hormonal therapy for locally advanced prostate cancer
下载PDF
导出
摘要 目的:探讨经直肠穿刺125Ⅰ粒子植入近距离放疗联合内分泌治疗局部晚期前列腺癌的临床疗效。方法:27例局部晚期前列腺癌患者采用经直肠超声引导下经直肠穿刺125Ⅰ粒子植入联合内分泌治疗,动态监测PSA、前列腺体积、最大尿流率、国际前列腺症状评分变化。结果:所有患者植入过程顺利,实际粒子植入时间20~35 min,植入粒子40~58粒。植入后6个月,27例患者PSA<0.2μg/L,其中19例<0.1μg/L;前列腺体积与植入前相比明显缩小[(36.38±6.20)ml vs(25.81±3.77)ml,P<0.05]、最大尿流率及国际前列腺症状评分较植入前明显改善[(8.43±2.97)m/s、(19.56±2.03)分vs(16.87±1.67)ml/s、(13.45±2.17)分,P<0.05]。随访至植入后3年,19例患者处于第一周期间歇期,8例患者处于第三周期治疗期,其中2例患者病情进展,转变为雄激素非依赖性前列腺癌,2例病情恶化发生早期骨转移。3年生化无进展生存率为70.4%(19/27)、临床无进展生存率85.2%(23/27)、治疗有效率92.6%(25/27)。27例患者没有严重并发症发生。结论:经直肠穿刺125Ⅰ粒子植入联合内分泌治疗局部晚期前列腺癌安全、微创,有效延缓疾病进程,无严重尿道、直肠、勃起功能障碍等并发症。 Objective : To evaluate the clinical efficacy of transrectal ^125I seeds implantation brachytherapy (BT) combined with intermittent hormonal therapy (IHT) in the treatment of locally advanced prostate cancer. Methods : We treated 27 patients with lo- cally advanced prostate cancer by transreetal ^125I seeds implantation BT combined with IHT, and dynamically observed the changes in the PSA level, prostate volume, maximum urinary flow rate (Qmax) and International Prostate Symptoms Score (IPSS). Results: All the implantation procedures were completed smoothly, lasting 20 to 35 minutes, with 40 to 58 seeds implanted. At 6 months afterimplantation, the PSA level was 〈0.2 μg/L in all the patients ( 〈0.1 μg/L in 19 cases), the prostate volume was significantly re- duced (P 〈0.05), and Qmax and IPSS remarkably improved (P 〈0.05). At 3 years after implantation, 19 cases were in the first cy- cle and the other 8 in the third cycle of IHT, of which 2 progressed to androgen-independent prostate cancer, and another 2 developed early bone metastasis. The rates of 3-year biochemicaUy and clinically progression-free survival were 70.3% and 85.2%, respectively, and the rate of therapeutic effectiveness was 92.6%. No severe complications occurred in any of the cases. Conclusion : Transrectal ^125I seeds implantation BT combined with IHT is a safe and minimally invasive procedure for locally advanced prostate cancer, which can effectively retard its chnical progression with no such complications as severe urethral, rectal or erectile dysfunction.
出处 《中华男科学杂志》 CAS CSCD 2013年第7期617-621,共5页 National Journal of Andrology
基金 国家自然科学基金青年科学基金(81001142) 广东省自然科学基金博士科研启动基金(10451001002004735)~~
关键词 经直肠穿刺粒子植入 125Ⅰ 近距离放疗 内分泌治疗 局部晚期前列腺癌 transrectal prostate seeds implantation ^125I brachytherapy hormonal therapy locally advanced prostate cancer
  • 相关文献

参考文献15

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011,61 (2) : 69-90.
  • 2Taira AV, Merrick GS, Butler WM, et al. Long-term outcome for clinically localized prostate cancer treated with permanent in- terstitial brachytherapy. Int J Radiat Oncol Biol Phys, 2011 , 79 (5) : 1336-1342.
  • 3Lee HK, Adams MT, Motta J. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation the- rapy. Brachytherapy, 2008, 7(1): 17-21.
  • 4张春霆,党瑞锋,徐勇,刘冉录,张志宏,杨阔,马宝杰,任海林,乔宝民.^(125)I粒子植入治疗前列腺癌122例临床分析[J].现代泌尿生殖肿瘤杂志,2011,3(6):336-337. 被引量:5
  • 5Warde P, Mason M, Ding K, et al. Combined androgen depriva- tion therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial. Lancet, 2011, 378(9809): 2104-2111.
  • 6Heidemcich A, yon Knobloch R, Hofmann R. Current status of cytotoxic chemotherapy in hormone refractory prostate cancer. Eur Urol, 2001, 39(2) : 121-130.
  • 7吕军,陈照阳,王尉,张源锋,邱晓拂,张利朝,胡卫列,徐文峰,叶章群.经直肠高强度聚焦超声系统治疗前列腺癌57例疗效分析[J].中华男科学杂志,2007,13(11):1005-1008. 被引量:8
  • 8Crook J, Ludgate C, Malone S, et al. Final report of multicenter canadian phase Ⅲ randomized trial of 3 versus 8 months of neoad- juvant androgen deprivation therapy before conventional dose ra- diotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys, 2009, 73(2) : 327-333.
  • 9Merrick GS, Butler WM, Galbreath RW, et al. Five-year bio- chemical outcome following permanent interstitial brach'ytherapy for clinical T1-T3 prostate cancer. Int J Radiat Oncol Biol Phys, 2001,51(1): 41-48.
  • 10Georgakopoulos J, Zygogianni A, Papadopoulos G, et al. Perma- nent implantation as brachytherapy technique for prostate carcino- ma - review of clinical trials and guidelines. Rev Recent Clin Trials, 2012, 7(3) : 173-180.

二级参考文献55

  • 1黄毅,马潞林,王俊杰,冉维强.^(125)I放射粒子植入治疗激素难治性前列腺癌[J].中华泌尿外科杂志,2004,25(10):701-703. 被引量:18
  • 2王晓雄,黄亮,洪宝发,文载律,刘悦,朱开常.前列腺癌根治术后无瘤生存期的影响因素分析[J].中华泌尿外科杂志,2005,26(6):379-382. 被引量:3
  • 3黄永汉,徐文峰,林哲,张海滨,刘建华,杨明,伍士伟,叶珊.经直肠高能聚焦超声前列腺消融术治疗高龄及高危良性前列腺增生48例报告[J].中华泌尿外科杂志,2005,26(7):494-494. 被引量:14
  • 4陈明,孙则禹,张古田,陈恕求,李俊龙,彭涛,戴玉田.经会阴^(125)I粒子组织间植入治疗局限性前列腺癌临床研究(附10例报告)[J].现代泌尿外科杂志,2007,12(2):101-103. 被引量:7
  • 5Figg WD, Franks ME, Venzon D, et al. Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer. World J Urol, 2004, 22 ( 6 ) : 425- 430.
  • 6D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer, 2002, 95 (2) : 281- 286.
  • 7Freedland SJ, Presti JC Jr, Kane CJ, et al. Do younger men have better biochemical outcomes after radical prostatectomy? Urology, 2004, 63(3) : 518-522.
  • 8Herold DM, Hanlon AL, Movsas B, et al. Age-related prostate cancer metastases. Urology, 1998, 51 (6): 985-990.
  • 9Benaim EA, Pace CM, Roehrborn CG. Gleason score predicts androgen independent progression after androgen deprivation the-rapy. Eur Urol, 2002, 42(1) : 12-17.
  • 10Pellizzon AC, Salvajoli J, Novaes P, et al. Updated results of high-dose rate brachytherapy and external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition. Int Braz J Urol, 2008, 34 ( 3 ) : 293- 301.

共引文献35

同被引文献163

引证文献19

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部